DGMKG/DGNC/DGPRÄC: Latrogenic nerve injuries in face operations {#j_iss-2017-2005_s_001}
===============================================================

Long-term incidence of sensory disturbance in the forehead after fronto-orbital advancement in isolated nonsyndromic synostosis {#j_iss-2017-2005_s_001_s_001}
-------------------------------------------------------------------------------------------------------------------------------

M. Engel^1^, J. Hoffmann^1^, M. Berger^1^, O. Ristow^1^, H. Bächli^1^, C. Freudlsperger^1^

^1^*Universitätsklinikum Heidelberg, Heidelberg*

**Background:**

In the majority of the craniofacial literature, preservation of the supraorbital nerve during fronto-orbital advancement (FOA) is recommended. However, only a few studies have evaluated the incidence of sensory disturbance in the forehead after FOA during long-term follow-up.

**Materials and methods:**

57 children who underwent FOA in their first year of life because of isolated nonsyndromiccraniosynostosis Including trigonocephaly, anterior plagiocephaly or oxycephaly, were evaluated for sensory disturbance in the frontal region with a minimum follow-up of 27 months.

**Results:**

An objective and repeatable measurement using the Semmes - Weinstein test was possible in 36 children children older than 5 years at last follow-up. We revealed no sensory deficits in all patients, even in 3 patients, where one of the supraorbital nerves was transected during FOA.

**Conclusion:**

As previous reports have suggested a full recovery of sensation after transection of the supraorbital nerve during FOA, the need to preserve the nerve has to be evaluated. However, as release of the nerve from the supraorbital rim is possible, we generally recommend preserving this structure, to minimize the risk of sensory deficits in the forehead region.
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**Background:**

Scarring and consecutive soft tissue atrophies with loss of prominent structures and landmarks can be caused by surgical resections for ablative cancer surgery, extensive trauma, following adjuvant radiation therapy, or birth-related defects and malformations. However, the loss of the integrity is especially important in complex aesthetic units such as the face. Therefore, this study introduces a two step concept for surgical soft tissue augmentation procedures in facial atrophy.

**Materials and methods:**

The introduced two step concept for facial soft tissue augmentation procedures uses microvascular de-epithelialized fat flaps from the anterolateral thigh (ALT-flap) in a first surgical procedure. After a consolidation phase of approximately six months, further corrective procedures or contouring of the transplant and or the iatrogenic scars can be performed in a second surgical intervention.

**Results:**

Four cases are presented in this current study. Two male patients with a history of malignant neoplasms and radiation therapy as well as two female patients with a form of progressive hemifacial atrophy (Parry-Romberg syndrome) are illustrated and surgical steps as well as postoperative results are displayed.

**Conclusion:**

This current concept tries to provide an algorithm, which might be a helpful guideline in the meticulous surgical care of complex facial atrophies following cancer surgery or birth-related malformations. The two step approach using microvascular de-epithelialized fat ALT-flaps in a first augmentative procedure and corrective surgery about six months later seem to provide reliable and stable long-term results.
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**Background:**

Computer-assisted surgery has been proven to be an effective technique in reconstructive craniomaxillo facial (CMF) surgery. Highly precise selective laser melted patient specific titanium implants (PSTI) which were introduced recently, lifted computer-assisted CMF reconstruction on a new level.

Aim of this paper is the description of a method for midfacial and orbital reconstruction which leads to more predictable results.

**Materials and methods:**

The facial defects of the patients were assessed in multiplanar and 3D views. Midfacial and/or orbital reconstructions were performed with following workflow:

1.  Preoperative virtual reconstruction was realized by the use iPlan-CMF software (Brainlab®). After automatic bone segmentation of the CT data set, virtual correction was completed by manipulating the segmented parts in form of mirroring the not affected side to the affected side, rotating, translating or deforming to achieve a virtual model of an ideal reconstruction.

2.  The ideal virtual reconstruction serves as basis for PSTI and surgical guides which were computer aided designed (CAD) by a medical engineer and computer aided manufactured (CAM) by selective laser melting technique (KLS-Martin®, DePuySynthes®, Materialise®). Before design approval the virtual implant was controlled virtually in iPlan-CMF software concerning size and fit.

3.  Surgery was performed using minimized standard surgical approaches as transconjunctival, intraoral, blepharoplasty or coronal approach. PSTI were positioned regarding best fit and/or in combination with intraoperative navigation (Brainlab®).

4.  At the end of the procedure Intraoperative 3D imaging with a 3D C-arm device (Siemens®, Ziehm®) and image fusion of the intraoperative scan with the preoperative virtual planning was performed in iPlan-CMF software in order to control the result and to replace postoperative imaging.

**Results:**

Up to now 19 patients could be treated with the described workflow successfully. The software iPlan CMF with the tool for automatic bone segmentation of standard CT-data in combination with easy manipulation of the segmented parts allows instant virtual reconstructions and reduces time for virtual reconstruction planning significantly. Size and fit of PSTI were satisfactory in all cases. Positioning of PSTI could be realized by the precise and well defined fit of the PSTI in the majority of the cases. Intraoperative navigation was used additionally in complex cases, where the position of Implants and bone fragments had to be proven several times. Intraoperative imaging with a 3D C-arm was easy to apply, requiring ca. 10 min time only. The direct intraoperative radiological 3D control and the image fusion of preoperative planning and intraoperative data sets enabled the surgeon to evaluate his surgical result intraoperatively before leaving the operating theatre and could replace postoperative imaging in the most cases. This led to a reduction of surgery time, enabled minimal invasive approaches and reduced the risks of sequelae. Additionally, radiation dose could be decreased as well. However, soft tissue deficiency and scaring can limit the esthetic outcome.

**Conclusion:**

The described workflow can improve surgeon's confidence in midfacial and orbital reconstruction and is part of the clinical routine in our hospital due to more predictable results. In addition, it reduces time for planning and surgical procedures with minimally invasive approaches and minimizes the risks of sequelae.
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**Background:**

Management of scars and volume deficits of the face is one of the final steps in the treatment of oncological and post trauma patients. So far filler therapy has only rarely been used in this subgroup of patients. To access the effect and patient satisfaction of filler therapy with Restylane^®^ in the postoperative setting of oncological and posttraumatic patients was investigated and analysed.

**Materials and methods:**

A target patient group with esthetic and functional needs was offered treatment with fillers vs. autologous fat augmentation for the correction of scars or volume deficits of the face. Following the first treatment with Restylane®, follow up with an interval of 2 months was performed for clinical assessment of the esthetic and functional results. Photo documentation and evaluation of patient satisfaction was extracted from medical records.

**Results:**

A total of 16 patients opted for treatment with Restylane^®^ for the correction of scars and especially volume deficits of the face. Of these 16 patients, 12 were oncological and 4 post trauma patients. Ten of the oncological patients received radiotherapy prior to filler therapy. Indications for filler therapy were predominantly functional (n=11), especially to improve lip competence and for volumetric expansion of the tongue to improve articulation as well as swallowing. In a minority (n=1) of this subgroup the purpose was for the correction of volume deficits. All posttraumatic patients had esthetic, rather than functional concerns and most patients had an average of three treatments. Overall patient satisfaction with treatment results was 70%, the success rate for functional treatment was 72% and for esthetic treatment 60%. The success rate for lip augmentation was clearly higher (78%) than the rate for tongue augmentation. There were no complications after treatment with Restylane^®^, not even in fully irradiated areas.

**Conclusion:**

Main indications for Restylane^®^ injections in oncological and post trauma patients were functional (lip closure, tongue augmentation for improved articulation and swallowing) and esthetic (volume) improvements. Within these patient groups, filler therapy was best used for the achievement of lip closure.

Filler therapy with Restylane^®^ for functional and esthetic indications of the face presents an efficient and less invasive alternative to fat augmentation or surgery.
